BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32933399)

  • 1. [Not Available].
    Steurer J
    Praxis (Bern 1994); 2020 Sep; 109(12):1003-1004. PubMed ID: 32933399
    [No Abstract]   [Full Text] [Related]  

  • 2. [Physiological recovery of vaginal flora, prophylaxis and treatment of bacterial vaginosis].
    Akush Ginekol (Sofiia); 2008; 47(5):47-8. PubMed ID: 19227776
    [No Abstract]   [Full Text] [Related]  

  • 3. Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis.
    Cohen CR; Wierzbicki MR; French AL; Morris S; Newmann S; Reno H; Green L; Miller S; Powell J; Parks T; Hemmerling A
    N Engl J Med; 2020 May; 382(20):1906-1915. PubMed ID: 32402161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study.
    Larsson PG; Stray-Pedersen B; Ryttig KR; Larsen S
    BMC Womens Health; 2008 Jan; 8():3. PubMed ID: 18197974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase 2a study assessing colonization efficiency, safety, and acceptability of Lactobacillus crispatus CTV-05 in women with bacterial vaginosis.
    Hemmerling A; Harrison W; Schroeder A; Park J; Korn A; Shiboski S; Foster-Rosales A; Cohen CR
    Sex Transm Dis; 2010 Dec; 37(12):745-50. PubMed ID: 20644497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial vaginosis: a review on clinical trials with probiotics.
    Mastromarino P; Vitali B; Mosca L
    New Microbiol; 2013 Jul; 36(3):229-38. PubMed ID: 23912864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotics for preventing recurrent bacterial vaginosis.
    Webb L
    JAAPA; 2021 Feb; 34(2):19-22. PubMed ID: 33448711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of intravaginal clindamycin and metronidazole therapy on vaginal lactobacilli in patients with bacterial vaginosis.
    Nyirjesy P; McIntosh MJ; Gattermeir DJ; Schumacher RJ; Steinmetz JI; Joffrion JL
    Am J Obstet Gynecol; 2006 May; 194(5):1277-82. PubMed ID: 16647910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probiotic strategies for the treatment and prevention of bacterial vaginosis.
    MacPhee RA; Hummelen R; Bisanz JE; Miller WL; Reid G
    Expert Opin Pharmacother; 2010 Dec; 11(18):2985-95. PubMed ID: 21080853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Summaries for patients. Factors related to bacterial vaginosis that persists or occurs again after treatment in women who have sex with women.
    Ann Intern Med; 2008 Jul; 149(1):I30. PubMed ID: 18591629
    [No Abstract]   [Full Text] [Related]  

  • 11. Vaginal retention of locally administered clindamycin.
    Eriksson K; Larsson PG; Nilsson M; Forsum U
    APMIS; 2011 Jun; 119(6):373-6. PubMed ID: 21569095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment considerations for bacterial vaginosis and the risk of recurrence.
    Chen JY; Tian H; Beigi RH
    J Womens Health (Larchmt); 2009 Dec; 18(12):1997-2004. PubMed ID: 20044862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Life in the littoral zone: lactobacilli losing the plot.
    Hay P
    Sex Transm Infect; 2005 Apr; 81(2):100-2. PubMed ID: 15800083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progress in research of relationship between vaginal
    He YN; Xiong HY; Zheng YJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Mar; 38(3):406-410. PubMed ID: 28329949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lactobor Intim vaginal gel for the treatment and prevention of bacterial vaginosis].
    Malinova M
    Akush Ginekol (Sofiia); 2009; 48 Suppl 2():32-3. PubMed ID: 20380096
    [No Abstract]   [Full Text] [Related]  

  • 16. POLARIS: efficacy and safety of a vaginal medical device in recurrent bacterial vaginosis-a multicenter, open-label, non-controlled, study with 10 months of follow-up.
    Murina F; Inghirami P; Biriș M; Sîrbu D; Barattini DF; Ardolino LI; Mangrella M; Casolati E; Roșu SM; Crișan C
    J Int Med Res; 2024 May; 52(5):3000605241239021. PubMed ID: 38726878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vaginal microflora and vagini].
    Shi YF
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jan; 44(1):3-5. PubMed ID: 19563052
    [No Abstract]   [Full Text] [Related]  

  • 18. Recurrent bacterial vaginosis.
    Hay PE
    Dermatol Clin; 1998 Oct; 16(4):769-73, xii-xiii. PubMed ID: 9891678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An exploratory pilot study evaluating the supplementation of standard antibiotic therapy with probiotic lactobacilli in south African women with bacterial vaginosis.
    Marcotte H; Larsson PG; Andersen KK; Zuo F; Mikkelsen LS; Brandsborg E; Gray G; Laher F; Otwombe K
    BMC Infect Dis; 2019 Sep; 19(1):824. PubMed ID: 31533663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BASIC study: is intravaginal boric acid non-inferior to metronidazole in symptomatic bacterial vaginosis? Study protocol for a randomized controlled trial.
    Zeron Mullins M; Trouton KM
    Trials; 2015 Jul; 16():315. PubMed ID: 26210791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.